BWAY
BrainsWay Ltd.
NASDAQ · ILHealthcareMedical - Devices
$16.50+4.90%
Price as of Jul 20, 2026
BWAY valuation
BrainsWay Ltd. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 51.81x
- P/E 2026E
- 61.25x
- P/E 2027E
- 51.40x
- P/E 2028E
- 33.97x
- P/S forward
- 9.07x
Trailing multiples
- P/E TTM
- 44.59x
- PEG TTM
- —
- Price / book
- 8.72x
- Price / sales
- 11.75x
- Price / cash flow
- 46.59x
Enterprise value
- Enterprise value
- $607.6M
- EV / sales
- 10.81x
- EV / EBITDA
- 48.34x
- EV / EBIT
- 105.63x
- Market cap
- $660.7M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.